The estimated Net Worth of Philip Irving Smith is at least 409 千$ dollars as of 31 August 2018. Mr. Smith owns over 10,000 units of IntriCon stock worth over 242,400$ and over the last 9 years he sold IIN stock worth over 0$. In addition, he makes 166,334$ as Independent Chairman of the Board at IntriCon.
Philip has made over 1 trades of the IntriCon stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 10,000 units of IIN stock worth 68,300$ on 31 August 2018.
The largest trade he's ever made was exercising 10,000 units of IntriCon stock on 31 August 2018 worth over 68,300$. On average, Philip trades about 556 units every 0 days since 2016. As of 31 August 2018 he still owns at least 10,000 units of IntriCon stock.
You can see the complete history of Mr. Smith stock trades at the bottom of the page.
Philip Irving Smith serves as Independent Chairman of the Board of the Company. He became a director in April 2016. Mr. Smith has served as a managing director at the investment banking firm, Duff & Phelps beginning in March 2017, where he focuses on the healthcare industry. Prior to that, Mr. Smith was a managing director with the investment banking firm, BMO Capital Markets (formerly Greene Holcomb Fisher). Prior to joining Greene Holcomb Fisher in 2011, Mr. Smith was President and Chief Executive Officer of Angeion Corporation, now MGC Diagnostics, a global medical technology company. Earlier experiences include being CEO of DGIMED Ortho, Executive Vice President of Business Development at Vital Images, and a healthcare investment banker at Piper Jaffray.
As the Independent Chairman of the Board of IntriCon, the total compensation of Philip Smith at IntriCon is 166,334$. There are 4 executives at IntriCon getting paid more, with Scott Longval having the highest compensation of 439,794$.
Philip Smith is 52, he's been the Independent Chairman of the Board of IntriCon since 2019. There are 6 older and 2 younger executives at IntriCon. The oldest executive at IntriCon Corporation is Robert Masucci, 82, who is the Independent Director.
Philip's mailing address filed with the SEC is 605 HIGHWAY 169 N, SUITE 400, MINNEAPOLIS, MN, 55441.
Over the last 20 years, insiders at IntriCon have traded over 1,264,046$ worth of IntriCon stock and bought 3,600 units worth 15,540$ . The most active insiders traders include Raymond Huggenberger、Michael Geraci、Mark Stephen Gorder. On average, IntriCon executives and independent directors trade stock every 47 days with the average trade being worth of 306,588$. The most recent stock trade was executed by Michael Geraci on 12 May 2022, trading 8,000 units of IIN stock currently worth 55,200$.
Headquartered in Arden Hills, Minn., IntriCon Corporation designs, develops and manufactures miniature interventional, implantable and body-worn medical devices. These advanced products help medical, healthcare and professional communications companies meet the rising demand for smaller, more intelligent and better-connected devices. IntriCon has facilities in the United States, Asia, the United Kingdom and Europe.
IntriCon executives and other stock owners filed with the SEC include: